The Clinical Efficacy of Azathioprine in Korean Patients with Atopic Dermatitis.

774 Ann Dermatol Received September 15, 2014, Revised February 12, 2015, Accepted for publication February 18, 2015 Corresponding author: Kwang Hoon Lee, Department of Dermatology and Cutaneous Biology Research Institute, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. Tel: 82-2-2228-2084, Fax: 82-2-393-9157, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Fig. 1. Change in the eczema area and severity index (EASI) score before and after azathioprine treatment (mean treatment duration, 22.20±19.84 weeks). There was a 42% reduction in the EASI score from the baseline (p<0.017). *Statistically significant difference compared with the baseline. incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014;4:e004833. 7. Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014;2:CD006866. 8. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993;18: 277-282.